Proposed new drug regulations will hurt all Canadians — and Ottawa has been warned

Financial Post

13 August 2019 - Changes which aim to make prescriptions more affordable could shut off entry of new drugs.

In December 2017, the federal government proposed amendments to the regulations governing the Patented Medicine Prices Review Board, the federal organisation that has set ceiling prices for new medicines for the past 30 years. The revisions are intended to make prescription medicines more affordable. The final regulations, shared last week in the dead of summer, are virtually the same as those originally proposed, despite strong concerns about their negative effects having been expressed by patients, the pharmaceutical industry and others.

The amendments, due to come into effect in July 2020, include three significant changes.

Read Financial Post article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , Regulation , Pricing , Canada